RxDoctor Payments Data

Ann Straight

Pediatric Endocrinology · San Antonio, TXNPI 1740244045

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,375 of the $4,984 with a category attached, or 67.7%. 26 manufacturers reported payments, led by Tandem Diabetes Care, Inc. at 34.9% of the total. Reporting peaked in 2019 at $3,690 and has fallen 99.2% since, to $31 in 2024.

$4,984in general payments, 2019–2025

Across 183 payments — averaging $27.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tandem Diabetes Care, Inc.$2K
  • Lilly USA, LLC$420
  • Novo Nordisk$378
  • AbbVie$321
  • Mannkind Corporation$269
  • Dexcom, Inc.$259
  • plus $2K from 20 others

What the payments were for

  • Speaking & faculty fees$1,55031%
  • Food & beverage$3,37568%
  • Gifts$591%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,984 in reported general payments places this provider in the 75th percentile of 120 pediatric endocrinology providers in Texas.

See all pediatric endocrinology providers in Texas

Other pediatric endocrinology in San Antonio

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →